JP was very positive about Daybue and said the numbers are becoming more certain. He is happy with the persistence rate and feels the new sales initiatives will see positive outcomes in the 3rd quarter. Any remaining questions about Daybue’s efficacy should now be put to rest
- Forums
- ASX - By Stock
- NEU
- Ann: AGM Chair Address & CEO Presentation
NEU
neuren pharmaceuticals limited
Add to My Watchlist
1.01%
!
$12.98

Ann: AGM Chair Address & CEO Presentation, page-36
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$12.98 |
Change
0.130(1.01%) |
Mkt cap ! $1.598B |
Open | High | Low | Value | Volume |
$13.15 | $13.15 | $12.92 | $490.1K | 37.39K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 11 | $12.96 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$12.98 | 672 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 16 | 14.070 |
6 | 859 | 13.770 |
1 | 270 | 13.690 |
1 | 11 | 13.560 |
1 | 1 | 13.540 |
Price($) | Vol. | No. |
---|---|---|
12.070 | 592 | 6 |
12.210 | 2792 | 10 |
12.650 | 348 | 4 |
12.680 | 46 | 2 |
12.710 | 1018 | 2 |
Last trade - 10.10am 18/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online